Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report

Authors

  • Vikash Paudel Department of Dermatology, National Medical College, Birgunj, Nepal https://orcid.org/0000-0001-8729-052X
  • Deepa Chudal Deputy superintendent of police, Nepal Police Hospital, Maharajgunj, Kathmandu, Nepal https://orcid.org/0000-0003-0610-3214
  • Manish Bhakta Pradhan Department of Dermatology, National Medical College, Birgunj, Nepal https://orcid.org/0000-0001-5220-6113
  • Rupa Thakur Department of Dermatology, National Medical College, Birgunj, Nepal
  • Buddhi Raj Pandey Department of Dermatology, National Medical College, Birgunj, Nepal

DOI:

https://doi.org/10.31729/jnma.5830

Keywords:

alopecia areata, alopecia universalis, azathioprine, hydroxychloroquine

Abstract

Alopecia universalis is an uncommon form of alopecia areata involving hair loss over the entire scalp and body. This condition is difficult to treat and sustain the growth of hair for longer duration. We report a case of alopecia universalis associated with severe hyperthyroidism. A lady in her fourth decade presented to us with gradual onset of alopecia universalis, who later found to have hyperthyroidism which was refractory to multiple treatment modalities. She was treated successfully with azathioprine and hydroxychloroquine. Alopecia universalis with less response to oral steroid
therapy was successfully managed with azathioprine with hydroxychloroquine.

Downloads

Published

2021-09-11

How to Cite

Paudel, V., Chudal, D., Pradhan, M. B., Thakur, R., & Pandey, B. R. (2021). Alopecia Universalis Associated with Hyperthyroidism Treated with Azathioprine and Hydroxychloroquine: A Case Report. Journal of Nepal Medical Association, 59(241), 935–937. https://doi.org/10.31729/jnma.5830

Issue

Vol. 59 No. 241 (2021): JNMA: Published Monthly

Section

Case Reports

License

Copyright (c) 2021 Vikash Paudel, Dr Deepa, Dr Manish, Dr Rupa, Dr Buddhi

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.